Home > > > > > Report Detail

Investigation Report on Chinese Enoxaparin Sodium Market, 2018-2022

Publisher Name :
Date: 05-Jul-2018
No. of pages: 30

Description

Heparin drugs are widely used in hemodialysis and various surgical operations. Compared with unfractionated heparin, low-molecular-weight heparin has the following advantages: no need to monitor thrombin time; smaller potential bleeding risk; smaller osteoporosis risk after long-term use; smaller risk of inducing thrombopenia.

Low-molecular-weight heparin preparations are gradually replacing unfractionated heparin preparations because of wider clinical applications. The main product of low-molecular-weight heparin preparations is Enoxaparin Sodium which was originally developed by Aventis (merged with Sanofi later) and approved to be sold in the trade name of Lovenox in 1993. Sanofi's Enoxaparin Sodium Injection was approved by FDA in Oct. 2004, and entered the Chinese market in the beginning of 2005 with a continuous growth in market size. Its sales value exceeded CNY 300 million in 2017.

Enoxaparin Sodium can be used to prevent deep vein thrombosis and pulmonary embolism, to treat established venous thrombosis, to prevent thrombus formation in extracorporeal circulation during hemodialysis, and to treat unstable angina and non-Q-wave myocardial infarction.

The market research, generic drugs also takes up some market share because the average price of Sanofi's products is comparatively high. Many pharmaceutical enterprises in China have obtained the production permit for Enoxaparin Sodium injection. CRI's market research shows that the Chinese market is dominated by Sanofi. Other major market players include Hangzhou Jiuyuan Gene Engineering Co., Ltd., Shenzhen Techdow Pharmaceutical Co., Ltd., etc. In 2017, the top 5 manufacturers took up over 90% market share by sales value, with Sanofi's market share reaching approximately 80%. Sanofi's market share is gradually flowing to domestic enterprises because of high average price. It is estimated that Sanofi will have ever smaller market share in the coming years with more Enoxaparin Sodium manufacturers entering the market in China.

The market research, as China's population ages, the incidence of vascular embolic disease continues to rise. At the same time, as the incidence of ESRD in China continues to rise, the number of people receiving hemodialysis is also rising. All these factors have driven the growth of the Enoxaparin Sodium market. There is still a large growth potential for the Chinese Enoxaparin Sodium market.

Topics Covered:


  • Incidence of thrombosis in China

  • Development history of Enoxaparin Sodium in China

  • Sales of Enoxaparin Sodium in China

  • Prices of Enoxaparin Sodium in China

  • Major Enoxaparin Sodium manufacturers in China

  • Prospects of Chinese Enoxaparin Sodium Market

Investigation Report on Chinese Enoxaparin Sodium Market, 2018-2022

Table of Contents

1 Relevant Concepts of Enoxaparin Sodium
1.1 Indications for Enoxaparin Sodium
1.2 Development History of Enoxaparin Sodium in China
1.3 Production Permit of Enoxaparin Sodium in China

2 Analysis on Sales of Enoxaparin Sodium in China, 2013-2017
2.1 Sales Value of Enoxaparin Sodium
2.1.1 Overall Sales Value
2.1.2 Sales Value in Key Regions of China
2.2 Sales Volume of Enoxaparin Sodium
2.2.1 Overall Sales Volume
2.2.2 Sales Volume in Key Regions of China
2.3 Sales of Enoxaparin Sodium in Different Dosage Forms in China

3 Major Enoxaparin Sodium Manufacturers in China, 2013-2017
3.1 Analysis on Market Shares of Major Enoxaparin Sodium Manufacturers in China
3.1.1 Market Shares by Sales Value
3.1.2 Market Shares by Sales Volume
3.2 Sanofi
3.2.1 Profile of Sanofi
3.2.2 Sales of Sanofi's Enoxaparin Sodium in China
(The structures of 3.3-3.6 are similar with that of 3.2.)
3.3 Hangzhou Jiuyuan Gene Engineering Co., Ltd.
3.4 Shenzhen Techdow Pharmaceutical Co., Ltd.
3.5 Nanjing King-friend Biochemical Pharmaceutical Co., Ltd.
3.6 Chengdu Baiyu Pharmaceutical Co., Ltd.
3.7 Suzhou Erye Pharmaceutical Co., Ltd.
3.8 Beijing SL Pharmaceutical Co., Ltd.
3.9 Changzhou Qianhong Bio-pharma Co., Ltd.

4 Prices of Enoxaparin Sodium in China, 2017-2018
4.1 Analysis on Average Price of Enoxaparin Sodium in China
4.2 Analysis on Prices of Enoxaparin Sodium in Different Regions of China
4.3 Analysis on Prices of Enoxaparin Sodium of Different Enterprises in China
4.3.1 Sanofi
4.3.2 Hangzhou Jiuyuan Gene Engineering Co., Ltd.
4.3.3 Shenzhen Techdow Pharmaceutical Co., Ltd.
4.3.4 Nanjing King-friend Biochemical Pharmaceutical Co., Ltd.
4.3.5 Chengdu Baiyu Pharmaceutical Co., Ltd.
4.3.6 Suzhou Erye Pharmaceutical Co., Ltd.
4.3.7 Beijing SL Pharmaceutical Co., Ltd.
4.3.8 Changzhou Qianhong Bio-pharma Co., Ltd.

5 Prospects of Chinese Enoxaparin Sodium Market, 2018-2022
5.1 Forecast on Incidence of Indications in China
5.2 Forecast on Size of Enoxaparin Sodium Market
5.3 Forecast on Trend of Enoxaparin Sodium Market

List of Charts

Chart Enoxaparin Sodium Products Approved to Market in China by 2018
Chart Sales Value of Enoxaparin Sodium in China, 2013-2017
Chart Sales Value of Enoxaparin Sodium by Region in China, 2013-2017
Chart Market Shares of Major Enoxaparin Sodium Manufacturers in China (by Sales Value)
Chart Price of Sanofi's Enoxaparin Sodium in China, 2017-2018
Chart Profile of Hangzhou Jiuyuan Gene Engineering Co., Ltd.
Chart Sales of Hangzhou Jiuyuan Gene Engineering Co., Ltd.'s Enoxaparin Sodium, 2013-2017
Chart Price of Hangzhou Jiuyuan Gene Engineering Co., Ltd.'s Enoxaparin Sodium in China, 2017-2018
Chart Forecast on Size of Chinese Enoxaparin Sodium Market, 2018-2022

  • Global Fibrinogen Concentrate Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The Fibrinogen Concentrate market covers Human Fibrinogen Concentrate, Other, etc. The typical players include CSL Behring, LFB, Shanghai RAAS, Boya, Hualan Biological Engineering, etc. The global Fibrinogen Concentrate market was valued at US$ 796 million in 2023 and is anticipated to reach US$ 2207.6 million by 2030, witnessing a CAGR of 15.5% during The forecast period 2024-2030. The major producers in The industry are CSL Behring, LFB Group and Shanghai RAAS B......
  • Global Fibrinogen Concentrate Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 91
    According to our LPI (LP Information) latest study, the global Fibrinogen Concentrate market size was valued at US$ 778.7 million in 2023. With growing demand in downstream market, the Fibrinogen Concentrate is forecast to a readjusted size of US$ 2211.3 million by 2030 with a CAGR of 16.1% during review period. The research report highlights the growth potential of the global Fibrinogen Concentrate market. Fibrinogen Concentrate are expected to show stable growth in the future market. H......
  • Global Low Molecular Weight Heparin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 124
    Market Overview of Global Low Molecular Weight Heparin market: According to our latest research, the global Low Molecular Weight Heparin market looks promising in the next 5 years. As of 2022, the global Low Molecular Weight Heparin market was estimated at USD 359.23 million, and it's anticipated to reach USD 601.59 million in 2028, with a CAGR of 8.97% during the forecast years. Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. They are used in the......
  • Global Anticoagulants Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106
    According to our LPI (LP Information) latest study, the global Anticoagulants market size was valued at US$ 25390 million in 2023. With growing demand in downstream market, the Anticoagulants is forecast to a readjusted size of US$ 35420 million by 2030 with a CAGR of 4.9% during review period. The research report highlights the growth potential of the global Anticoagulants market. Anticoagulants are expected to show stable growth in the future market. However, product differentiation, r......
  • Global Injectable Anticoagulants Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Injectable Anticoagulants market size was valued at US$ 5959.5 million in 2023. With growing demand in downstream market, the Injectable Anticoagulants is forecast to a readjusted size of US$ 6929.9 million by 2030 with a CAGR of 2.2% during review period. The research report highlights the growth potential of the global Injectable Anticoagulants market. Injectable Anticoagulants are expected to show stable growth in the futu......
  • Global Low Molecular Weight Heparin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88
    According to our LPI (LP Information) latest study, the global Low Molecular Weight Heparin market size was valued at US$ 331.2 million in 2023. With growing demand in downstream market, the Low Molecular Weight Heparin is forecast to a readjusted size of US$ 485.1 million by 2030 with a CAGR of 5.6% during review period. The research report highlights the growth potential of the global Low Molecular Weight Heparin market. Low Molecular Weight Heparin are expected to show stable growth i......
  • Global Heparin Sodium Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132
    According to our LPI (LP Information) latest study, the global Heparin Sodium market size was valued at US$ 3301.4 million in 2023. With growing demand in downstream market, the Heparin Sodium is forecast to a readjusted size of US$ 5093.5 million by 2030 with a CAGR of 6.4% during review period. The research report highlights the growth potential of the global Heparin Sodium market. Heparin Sodium are expected to show stable growth in the future market. However, product differentiation,......
  • Global Intravenous Immunoglobulin (IVIg) Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 120
    According to our LPI (LP Information) latest study, the global Intravenous Immunoglobulin (IVIg) market size was valued at US$ 10090 million in 2023. With growing demand in downstream market, the Intravenous Immunoglobulin (IVIg) is forecast to a readjusted size of US$ 15290 million by 2030 with a CAGR of 6.1% during review period. The research report highlights the growth potential of the global Intravenous Immunoglobulin (IVIg) market. Intravenous Immunoglobulin (IVIg) are expected to ......
  • Global Heparin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 128
    According to our LPI (LP Information) latest study, the global Heparin market size was valued at US$ 2286.2 million in 2023. With growing demand in downstream market, the Heparin is forecast to a readjusted size of US$ 3831.5 million by 2030 with a CAGR of 7.7% during review period. The research report highlights the growth potential of the global Heparin market. Heparin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs